Business Description
NurExone Biologic Inc
NAICS : 325412
SIC : 3741
ISIN : CA67059R1091
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 96.15 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate | 13.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.42 | |||||
9-Day RSI | 40.07 | |||||
14-Day RSI | 43.88 | |||||
6-1 Month Momentum % | -16.67 | |||||
12-1 Month Momentum % | 120 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.1 | |||||
Quick Ratio | 5.1 | |||||
Cash Ratio | 4.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.92 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -265.32 | |||||
ROA % | -169.81 | |||||
ROIC % | -730.53 | |||||
ROC (Joel Greenblatt) % | -1423.91 | |||||
ROCE % | -244.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 10.57 | |||||
Price-to-Tangible-Book | 11.2 | |||||
EV-to-EBIT | -6.54 | |||||
EV-to-EBITDA | -6.62 | |||||
EV-to-FCF | -6.48 | |||||
Price-to-Net-Current-Asset-Value | 14 | |||||
Price-to-Net-Cash | 18.67 | |||||
Earnings Yield (Greenblatt) % | -15.29 | |||||
FCF Yield % | -14.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NurExone Biologic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.107 | ||
Beta | 0 | ||
Volatility % | 104.2 | ||
14-Day RSI | 43.88 | ||
14-Day ATR (C$) | 0.021155 | ||
20-Day SMA (C$) | 0.573 | ||
12-1 Month Momentum % | 120 | ||
52-Week Range (C$) | 0.25 - 1.19 | ||
Shares Outstanding (Mil) | 67.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NurExone Biologic Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NurExone Biologic Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
NurExone Biologic Inc Frequently Asked Questions
What is NurExone Biologic Inc(TSXV:NRX)'s stock price today?
When is next earnings date of NurExone Biologic Inc(TSXV:NRX)?
Does NurExone Biologic Inc(TSXV:NRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |